Bavarian Stock Today

<div class='circular--portrait' style='background:#347AFC;color: #ffffff;font-size:4em;padding-top: 25px;;'>BN</div>
Equity ratings for Bavarian Nordic AS are calculated daily based on the scoring framework. The performance scores are derived for the period starting the 25th of February 2020 and ending today, the 25th of May 2020. Click here to learn more.
Analyze Filter   Check how we calculate scores
Bavarian Nordic AS cannot be verified against its exchange. It appears that Bavarian Nordic is not available for investing at the moment. Please verify the symbol is currently traded on Copenhagen Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Bavarian Nordic Profile

Bavarian Nordic AS, a biotechnology company, develops, manufactures, and commercializes a portfolio of cancer immunotherapies and vaccines for infectious diseases. Bavarian Nordic AS was founded in 1994 and is based in Kvistgrd, Denmark. Bavarian Nordic operates under Biotechnology classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 419 people.. The public information regarding Bavarian Nordic AS's current market price is not available at this time.
Legal NameBavarian Nordic AS
President CEOPaul ChaplinView All
Thematic Classification
Currently Active Investing Idea
  Healthcare
View All
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
Bavarian Nordic AS (BAVA) is traded on Copenhagen Stock Exchange in Denmark and employs 419 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 6.2 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bavarian Nordic's market, we take the total number of it shares issued and multiply it by the Bavarian Nordic's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Bavarian Nordic AS operates under Healthcare sector and is part of Biotechnology industry. The entity has 32.25 M outstanding shares. BAVARIAN NORDIC has accumulated about 1.93 B in cash with (152.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 59.99.
Check Bavarian Nordic Probability Of Bankruptcy

Bavarian Stock Against Markets

Bavarian Nordic AS cannot be verified against its exchange. It appears that Bavarian Nordic is not available for investing at the moment. Please verify the symbol is currently traded on Copenhagen Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

Bavarian Nordic Corporate Directors

Peter KursteinJensen Independent Director
Claus Braestrup Independent Director
Erik Hansen Independent Director
Check out Trending Equities. Please also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page